Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CDTX

Cidara Therapeutics

$4.13

0.01 (0.24%)

17:24
11/08/18
11/08
17:24
11/08/18
17:24
Earnings
Cidara Therapeutics reports Q3 EPS (49c), consensus (60c) »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDTX

Cidara Therapeutics

$4.13

0.01 (0.24%)

16:40
11/08/18
11/08
16:40
11/08/18
16:40
Syndicate
Breaking Syndicate news story on Cidara Therapeutics »

Cidara Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CDTX

Cidara Therapeutics

$4.45

-0.05 (-1.11%)

08:05
09/27/18
09/27
08:05
09/27/18
08:05
Hot Stocks
Cidara Therapeutics initiates Phase 3 trial of rezafungin »

Cidara Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

CDTX

Cidara Therapeutics

$4.25

0.05 (1.19%)

08:10
09/25/18
09/25
08:10
09/25/18
08:10
Hot Stocks
Cidara Therapeutics: Cidara granted FDA QIDP, Fast Track Designations »

Cidara Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

Over a quarter ago
CDTX

Cidara Therapeutics

$4.25

0.05 (1.19%)

16:13
08/17/18
08/17
16:13
08/17/18
16:13
Hot Stocks
Cidara Therapeutics CFO Onaitis steps down to pursue other opportunities »

Cidara Therapeutics said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

CDTX

Cidara Therapeutics

$3.90

0.25 (6.85%)

16:59
08/08/18
08/08
16:59
08/08/18
16:59
Earnings
Cidara Therapeutics reports Q2 EPS ($1.13), consensus (66c) »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

GOOD

Gladstone

$19.65

(0.00%)

, TERP

TerraForm Power

$10.28

(0.00%)

10:39
07/26/18
07/26
10:39
07/26/18
10:39
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

GOOD

Gladstone

$19.65

(0.00%)

TERP

TerraForm Power

$10.28

(0.00%)

CASA

Casa Systems

$15.40

-0.26 (-1.66%)

CDTX

Cidara Therapeutics

$4.30

(0.00%)

IPHI

Inphi

$34.25

0.875 (2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 08

    Aug

  • 14

    Aug

CDTX

Cidara Therapeutics

$4.30

-0.15 (-3.37%)

07:29
07/26/18
07/26
07:29
07/26/18
07:29
Initiation
Cidara Therapeutics initiated at Citi »

Cidara Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDTX

Cidara Therapeutics

$4.30

-0.15 (-3.37%)

16:21
07/25/18
07/25
16:21
07/25/18
16:21
Initiation
Cidara Therapeutics initiated at Citi »

Cidara Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDTX

Cidara Therapeutics

$5.20

-0.25 (-4.59%)

16:13
06/21/18
06/21
16:13
06/21/18
16:13
Syndicate
Breaking Syndicate news story on Cidara Therapeutics »

Cidara Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.